Search Results - Tung‐Hung Su
- Showing 1 - 20 results of 30
- Go to Next Page
-
1
The clinical manifestations and management of COVID-19-related liver injury by Tung‐Hung Su, Jia‐Horng Kao
Published 2020Artigo -
2
-
3
Artificial intelligence in precision medicine in hepatology by Tung‐Hung Su, Chih–Horng Wu, Jia‐Horng Kao
Published 2021Artigo -
4
-
5
-
6
-
7
Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection by Chen‐Hua Liu, Chun‐Jen Liu, Tung‐Hung Su, Yu‐Jen Fang, Hung‐Chih Yang, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao
Published 2017Artigo -
8
-
9
Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C by Tung‐Hung Su, Chen‐Hua Liu, Chun‐Jen Liu, Chi‐Ling Chen, Te‐Tien Ting, Tai–Chung Tseng, Pei‐Jer Chen, Jia‐Horng Kao, Ding‐Shinn Chen
Published 2013Artigo -
10
-
11
-
12
Serum Hepatitis B Virus-DNA Levels Correlate With Long-term Adverse Outcomes in Spontaneous Hepatitis B e Antigen Seroconverters by Tai–Chung Tseng, Chun‐Jen Liu, Chi‐Ling Chen, Chia‐Chi Wang, Tung‐Hung Su, Stephanie Fang‐Tzu Kuo, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao
Published 2011Artigo -
13
Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice by Wei‐Hsiang Lin, Shiou‐Hwei Yeh, Kun‐Huei Yeh, Kai-Wei Chen, Ya‐Wen Cheng, Tung‐Hung Su, Ping Jao, Lin-Chun Ni, Pei‐Jer Chen, Ding‐Shinn Chen
Published 2016Artigo -
14
-
15
Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial by Jeong Heo, Ja‐Der Liang, Chang Won Kim, Hyun Young Woo, I‐Lun Shih, Tung‐Hung Su, Zhong‐Zhe Lin, So Young Yoo, Stanley Chang, Yasuo Urata, Pei‐Jer Chen
Published 2023Artigo -
16
Adjacent Cell Marker Lateral Spillover Compensation and Reinforcement for Multiplexed Images by Yunhao Bai, Bokai Zhu, Xavier Rovira‐Clavé, Han Chen, Maxim Markovic, Chi Ngai Chan, Tung-Hung Su, David R. McIlwain, Jacob D. Estes, Leeat Keren, Garry P. Nolan, Sizun Jiang
Published 2021Artigo -
17
Hepatitis C viral infection increases the risk of lymphoid‐neoplasms: A population‐based cohort study by Tung‐Hung Su, Chun‐Jen Liu, Tai–Chung Tseng, Shih‐Wan Chou, Chen‐Hua Liu, Hung‐Chih Yang, Shang‐Ju Wu, Pei‐Jer Chen, Ding‐Shinn Chen, Chi‐Ling Chen, Jia‐Horng Kao
Published 2015Artigo -
18
Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B by Tung‐Hung Su, Ching‐Sheng Hsu, Chi‐Ling Chen, Chen‐Hua Liu, Yi‐Wen Huang, Tai–Chung Tseng, Chun‐Jen Liu, Pei‐Jer Chen, Ming‐Yang Lai, Ding‐Shinn Chen, Jia‐Horng Kao
Published 2010Artigo -
19
High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load by Tai–Chung Tseng, Chun‐Jen Liu, Hung‐Chih Yang, Tung‐Hung Su, Chia–Chi Wang, Chi‐Ling Chen, Stephanie Fang‐Tzu Kuo, Chen‐Hua Liu, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao
Published 2012Artigo -
20
Young Chronic Hepatitis B Patients With Nucleos(t)ide Analogue-induced Hepatitis B e Antigen Seroconversion Have a Higher Risk of HBV Reactivation by Tai–Chung Tseng, Chun‐Jen Liu, Tung‐Hung Su, Hung‐Chih Yang, C.-C. Wang, C.-L. Chen, Stephanie Fang‐Tzu Kuo, Chen‐Hua Liu, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao
Published 2012Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Immunology
Virus
Hepatitis B
Hepatitis B virus
Virology
Gastroenterology
Biology
HBsAg
Hepatocellular carcinoma
Confidence interval
Hazard ratio
HBeAg
Chronic hepatitis
Cirrhosis
Biochemistry
Gene
Cohort
Genetics
Genotype
Hepatitis C virus
Oncology
Pathology
Viral load
Antibody
Cancer
Cancer research
Chemistry
Disease